Interleukin-15 enhances HIV-1-driven polyclonal B-cell response in vitro

被引:24
作者
Kacani, L
Sprinzl, GM
Erdei, A
Dierich, MP
机构
[1] Leopold Franzens Univ, Inst Hyg, A-6020 Innsbruck, Austria
[2] Leopold Franzens Univ, Univ Klin Hals Nasen & Ohrenheilkunde, A-6020 Innsbruck, Austria
[3] Eotvos Lorand Univ, Dept Immunol, God, Hungary
关键词
hypergammaglobulinaemia; interleukin-15; HIV-1; IgG; IgM; IgA;
D O I
10.1159/000019108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-15 (IL-15) is a recently described cytokine, produced by monocytes/macrophages, with biological activities similar to IL-2. Since IL-15 was shown to stimulate human B-cell proliferation and immunoglobulin secretion, we investigated its effect on human B-cells stimulated with heat-inactivated human immunodeficiency virus type 1 (iHIV-1) in vitro. We observed a dose-dependent elevation of [H-3]-thymidine incorporation and immunoglobulin production by B-cells incubated in the presence of iHIV-1. Moreover, IL-15 stimulated HIV-1-driven B-cell proliferation similarly to IL-2. As to immunoglobulin secretion, IL-15 was able to potentiate the stimulatory effect of IL-10. The highest amounts of iHIV caused a decrease in B-cell proliferation and immunoglobulin secretion to baseline levels, even in the presence of cytokines. These findings indicate that during the late stages of AIDS, when monocytes/macrophages become the major site of viral production, IL-15, in concert with other monocyte-derived cytokines, may promote polyclonal B-cell activation and hypergammaglobulinaemia, which are frequently associated with HIV infection.
引用
收藏
页码:162 / 172
页数:11
相关论文
共 34 条
[1]   Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome [J].
Agostini, C ;
Trentin, L ;
Sancetta, R ;
Facco, M ;
Tassinari, C ;
Cerutti, A ;
Bortolin, M ;
Milani, A ;
Siviero, M ;
Zambello, R ;
Semenzato, G .
BLOOD, 1997, 90 (03) :1115-1123
[2]  
AMADORI A, 1991, J IMMUNOL, V146, P57
[3]  
ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
[4]   LIGAND-BINDING KINETICS OF IL-2 AND IL-15 TO HETEROMERS FORMED BY EXTRACELLULAR DOMAINS OF THE 3 IL-2 RECEPTOR SUBUNITS [J].
BALASUBRAMANIAN, S ;
CHERNOVROGAN, T ;
DAVIS, AM ;
WHITEHORN, E ;
TATE, E ;
BELL, MP ;
ZURAWSKI, G ;
BARRETT, RW .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (11) :1839-1849
[5]  
BENJAMIN D, 1992, BLOOD, V80, P1289
[6]   IMMUNOGLOBULIN-V(H)3 GENE-PRODUCTS - NATURAL LIGANDS FOR HIV GP120 [J].
BERBERIAN, L ;
GOODGLICK, L ;
KIPPS, TJ ;
BRAUN, J .
SCIENCE, 1993, 261 (5128) :1588-1591
[7]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[8]   Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro [J].
Carson, WE ;
Ross, ME ;
Baiocchi, RA ;
Marien, MJ ;
Boiani, N ;
Grabstein, K ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2578-2582
[9]  
CHIRMULE N, 1993, J IMMUNOL, V150, P2478
[10]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110